Deutsche Bank Ag\ Clene Inc. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.1 - $4.12 $22,209 - $43,573	-10,576 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.42 - $4.42 $3,189 - $5,825	-1,318 Reduced 11.08%	10,576 $42,000
Q4 2021 Feb 11, 2022	BUY	$3.95 - $7.53 $2,409 - $4,593	610 Added 5.41%	11,894 $49,000
Q3 2021 Nov 04, 2021	SELL	$6.83 - $13.58 $15,715 - $31,247	-2,301 Reduced 16.94%	11,284 $77,000
Q2 2021 Aug 11, 2021	BUY	$6.98 - $13.33 $94,823 - $181,088	13,585 New	13,585 $153,000

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.